Overview: This webinar will examine the existing and proposed requiements for the FDA's DHF and the MDD's TF/DD. Differing purposes / goals.
Differing purposes / goals. Required and desirable contents. Areas requiring frequent re-evaluation / update. Similiarities and differences, and future trends. Typical DHF Table of Contents. Technical File or Design Dossier Table of Contents. The importance and usefulness of the "Essential Requirements". Structure of the "Declaration of Conformity"; self-declaring or N-B reviewed. Parallel approaches to development. Differing approaches to file audits by the FDA and the Notified Body.
Areas Covered in the Session:
The EU's MDD and the Technical File / Design Dossier
Design Contol vs. a Product 'Snapshot in Time'
DHF "Typical" Contents
TF / DD Expected Contents
Parallel Approaches to Documentation - Teams
Future Directions
FDA and NB Audit Focus
Who Will Benefit:
Senior management in Drugs, Devices, Biologics, Dietary Supplements